Jump to content
RemedySpot.com

NATAP/IAC: HIV & Lipodystrophy

Rate this topic


Recommended Posts

Guest guest
Posted

Study

Suggests HIV Itself Unleashes Body-Fat-Change Cascade, Gene Study Suggests

 

XVII International AIDS

Conference, August 3-8, 2008, Mexico City

Mark MascoliniResults of gene studies imply that HIV-1

infection itself alters metabolic and inflammatory workings in a way that

promotes the body-fat changes collectively called HIV-associated lipodystrophy

(HALS) [1]. But antiretroviral therapy upsets these functions even more,

according to results of a four-group comparison.

Analyzing whole-gene

expression in adipose tissue (fat) RNA by two methods, University of Barcelona

investigators studied four groups: healthy controls without HIV infection,

HIV-infected people who never took antiretrovirals, HIV-infected people who

took antiretrovirals but did not have HALS, and HIV-infected, treated people

who had HALS. Francesc Villarroya and colleagues matched controls to the

HIV-infected groups by age. They looked for genetic markers by whole genome

array analysis in RNA extracted from fat tissue and by quantitative RT-PCR of

selected genes.

Compared with healthy

controls, the antiretroviral-naive HIV group had altered expression of:

·      Inflammation-related genes triggered by chemokines

and cytokines

·      Immunity-related genes controlled by interferon,

antibodies, and complement

·      Genes related to T-cell activation

Specifically, compared with

controls, people with HIV but still naive to antiretrovirals differed

significantly in expression of genes that control numerous metabolic and

inflammatory functions: complement-mediated immunity (P = 0.015), interferon-mediated immunity (P = 0.016), B-cell and antibody-mediated immunity (P = 0.025), T-cell activation (P < 0.001), inflammation mediated by chemokines and

cytokines (P = 0.006), fatty acid

beta oxidation (P = 0.003), and the

TCA cycle of oxidative metabolism (P < 0.001).

Differences in expression of

critical genes grew more marked in antiretroviral-treated people without HALS,

and worse still in treated people with HALS. Both antiretroviral-treated groups

differed from controls in levels of macrophage-mediated immunity (P = 0.011 for people without HALS and P = 0.009 for people with HALS).Only people with HALS

differed significantly from controls in expression of genes controlling MHC-1-

and MHC-2-mediated immunity (P =

0.002 and P = 0.010). And only

the HALS group differed significantly from controls in genes regulating fatty

acid metabolism (P = 0.013),

lipid and fatty acid transport (P

= 0.015), oxidative phosphorylation (P = 0.035), electron transport (P = 0.016), and apoptosis (P

= 0.047).

Even before HIV-infected

people start taking antiretrovirals, the investigators concluded, the virus

itself "causes early alterations in adipose tissue gene expression,

evidenced by induction of a pro-inflammatory status before full-blown

macrophage infiltration, and first signs of impaired adipogenesis and lipid

metabolism."

Villarroya and colleagues

proposed a complex inflammatory cascade beginning with a "first wave"

of pro-inflammatory signaling by HIV itself, leading to repression of lipid

accretion genes, repression of genes regulating adipocyte differentiation, and

activation of lipid catabolism genes. A "second wave" of

pro-inflammatory signaling, touched off by antiretroviral therapy, results in

enhanced lipid catabolism, impaired adipocyte differentiation, adipocyte

apoptosis, systemic metabolic disturbances linked to altered adipokine release,

and ultimately lipoatrophy.

One limitation of this kind

of analysis, observed antiretroviral toxicity expert Carr, is that

countless factors affect gene expression and it is impossible to balance out

their influence in a case-control comparison.

Reference

1. Villarroya F, Guallar JP, Domingo P, et al. Whole genome transcriptomic

analysis of adipose tissue from patients at distinct stages of progression of

HIV-1/HAART-associated lipodystrophy reveals alterations in inflammation and

metabolism due to HIV-1 infection before antiretroviral treatment. XVII

International AIDS Conference. August 3-8, 2008. Mexico City. Abstract WEAB0103.

 

It's time to go back to school! Get the latest trends and gadgets that make the grade on AOL Shopping.

Join the conversation

You are posting as a guest. If you have an account, sign in now to post with your account.
Note: Your post will require moderator approval before it will be visible.

Guest
Reply to this topic...

×   Pasted as rich text.   Paste as plain text instead

  Only 75 emoji are allowed.

×   Your link has been automatically embedded.   Display as a link instead

×   Your previous content has been restored.   Clear editor

×   You cannot paste images directly. Upload or insert images from URL.

Loading...
×
×
  • Create New...